Your browser doesn't support javascript.
loading
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes.
Seino, Yutaka; Terauchi, Yasuo; Osonoi, Takeshi; Yabe, Daisuke; Abe, Nobuyuki; Nishida, Tomoyuki; Zacho, Jeppe; Kaneko, Shizuka.
Affiliation
  • Seino Y; Kansai Electric Power Medical Research Institute, Kobe, Japan.
  • Terauchi Y; Kansai Electric Power Hospital, Osaka, Japan.
  • Osonoi T; Yokohama City University, Yokohama, Japan.
  • Yabe D; Naka Memorial Clinic, Ibaraki, Japan.
  • Abe N; Kansai Electric Power Medical Research Institute, Kobe, Japan.
  • Nishida T; Kansai Electric Power Hospital, Osaka, Japan.
  • Zacho J; Kyoto University, Kyoto, Japan.
  • Kaneko S; Abe Clinic, Oita, Japan.
Diabetes Obes Metab ; 20(2): 378-388, 2018 02.
Article in En | MEDLINE | ID: mdl-28786547
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Sitagliptin Phosphate / Glucagon-Like Peptide-1 Receptor / Hyperglycemia Type of study: Clinical_trials / Observational_studies / Prognostic_studies Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2018 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Sitagliptin Phosphate / Glucagon-Like Peptide-1 Receptor / Hyperglycemia Type of study: Clinical_trials / Observational_studies / Prognostic_studies Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2018 Type: Article Affiliation country: Japan